In vitro study of the hypercoagulable state in multiple myeloma patients treated or not with thalidomide.
Petropoulou
Anna D
AD
Service d'Hématologie Biologique, Hôpital Hôtel-Dieu, Assistance Publique Hôpitaux de Paris, France. annakyla@hotmail.com
Gerotziafas
Grigoris T
GT
Samama
Meyer M
MM
Hatmi
Mohamed
M
Rendu
Francine
F
Elalamy
Ismail
I
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001777:Blood Coagulation; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009101:Multiple Myeloma / Q000097:blood* / Q000188:drug therapy; D013792:Thalidomide / Q000009:adverse effects*; D013917:Thrombin / Q000096:biosynthesis*; D018180:Thrombomodulin / Q000097:blood*
D018180:Thrombomodulin; D013792:Thalidomide; D013917:Thrombin